Skip to Content

Join the 'Opiate Withdrawal' group to help and get support from people like you.

Opiate Withdrawal News

Related terms: Opioid Withdrawal

Opioid Crisis, Suicides Driving Decline in U.S. Life Expectancy: CDC

Posted 18 days ago by Drugs.com

THURSDAY, Nov. 29, 2018 – Life expectancy in the United States has now declined for three years in a row, fueled largely by a record number of drug overdose deaths and rising suicide rates, new government statistics show. "It's really the first time we've seen this multi-year drop" in decades, said Renee Gindi, chief of the Analytic Studies Branch of the National Center for Health Statistics ...

Many Drugstores Won't Dispense Opioid Antidote Naloxone as Required

Posted 13 Nov 2018 by Drugs.com

TUESDAY, Nov. 13, 2018 – People who overdose on opioids have one lifeline, the drug naloxone, but two new studies find that many pharmacies won't offer this lifesaving antidote without a doctor's blessing. Though many states have passed laws mandating that naloxone be made available without a prescription, researchers from California found that fewer than 25 percent of pharmacies in that state ...

U.S. OD Death Rate Worst Among Wealthier Nations

Posted 12 Nov 2018 by Drugs.com

MONDAY, Nov. 12, 2018 – With the rate of drug overdose deaths more than doubling since the turn of the century, the United States now leads the world in these preventable tragedies. New research from investigators at the U.S. National Cancer Institute (NCI) indicates that drug-related death rates in the United States are now more than double what they are in many other developed nations. For the ...

Only a Quarter of Opioid Painkillers Taken After Most Surgeries

Posted 7 Nov 2018 by Drugs.com

WEDNESDAY, Nov. 7, 2018 – Surgery patients typically use only one-quarter of the opioids they're prescribed for post-operative pain, a new study finds. And those leftover pills pose a risk of misuse, addiction and overdose, researchers at the University of Michigan said. "It's striking to see the major discrepancy between prescribed amount and the amount patients actually take," said study ...

Kratom Use in Pregnancy Spurs Withdrawal Symptoms in Newborns

Posted 7 Nov 2018 by Drugs.com

WEDNESDAY, Nov. 7, 2018 – Although the herbal supplement kratom is still legal and widely available, its opioid-like effects have caused significant withdrawal symptoms in at least two newborns in the United States and that should raise concerns, researchers say. A case study of a baby boy exposed to kratom during his mother's pregnancy – only the second American case reported – likely ...

Firsthand 9/11 Exposure Fueling Alcohol- and Drug-Related Deaths: Study

Posted 29 Oct 2018 by Drugs.com

MONDAY, Oct. 29, 2018 – People directly exposed to the World Trade Center terrorist attacks appear at increased risk of drug- and alcohol-related death, a new study finds. "Following a major disaster, alcohol- and drug-related mortality may be increased," said Dr. Jim Cone and colleagues of the New York City Department of Health and Mental Hygiene. For the study, the researchers analyzed data on ...

A Couple's Tough Trek Back From Opioid Addiction

Posted 4 Oct 2018 by Drugs.com

THURSDAY, Oct. 4, 2018 – In 2016, almost 174 Americans died each day due to drug overdoses – and roughly two-thirds of those deaths were caused by opioid drugs. The statistics are startling and make the problem seem hopeless. But is it? Beating drug addiction – whether it's opioids (such as OxyContin), methamphetamine or something else – is definitely a challenge and an ongoing process. ...

Coffee Shop Workers on Front Lines of Opioid Crisis

Posted 25 Sep 2018 by Drugs.com

MONDAY, Sept. 24, 2018 – New research suggests that employees in coffee shops and fast food places can be trained to respond to opioid overdoses at their places of business. "Because opioid overdoses may occur in public bathrooms, business managers and staff unwittingly become first responders. Providing training to service industry employees on how to respond to an overdose and administer ...

Cassipa Approved for Opioid Dependence

Posted 11 Sep 2018 by Drugs.com

MONDAY, Sept. 10, 2018 – Cassipa (buprenorphine and naloxone), a film designed to be placed under the tongue, has been approved to treat opioid dependence, the agency said in a news release. Both buprenorphine and naloxone have been approved previously for this purpose. "Opioid replacement therapy can be an important part of effective treatment," said FDA Commissioner Dr. Scott Gottlieb. "Opioid ...

More Opioid Users Getting Treatment Since Medicaid Expansion

Posted 17 Aug 2018 by Drugs.com

FRIDAY, Aug. 17, 2018 – The expansion of Medicaid that came along with the Affordable Care Act has made it easier for some opioid users to get treatment, new research suggests. In a study of nearly 12 million Medicaid patients, researchers found that while the number of prescriptions for opioid painkillers decreased slightly, prescriptions for buprenorphine (Buprenex), a drug to treat addiction, ...

Opioid Addicts Turning to Unapproved Antidepressant to Get High

Posted 2 Aug 2018 by Drugs.com

THURSDAY, Aug. 2, 2018 – In a trend that suggests opioid addicts are turning to new fixes, a government report shows that use of an unapproved antidepressant is becoming more widespread in the United States. Tianeptine is used in some European, Asian and Latin American countries for treatment of depression and anxiety. But the U.S. Food and Drug Administration has not approved use of the drug in ...

FDA Approves Non-Opioid Medication, Lucemyra (Lofexidine), to Treat Opioid Withdrawal

Posted 17 May 2018 by Drugs.com

THURSDAY, May 17, 2018 – The U.S. Food and Drug Administration on Wednesday approved the non-opioid drug Lucemyra to help adults cope with symptoms of opioid withdrawal. The drug can help addicts boost the odds that they will be able to kick their addiction to these powerful painkillers, the FDA said. It was fast-tracked for approval under the agency's Priority Review amid ongoing concerns about ...

Non-Opioid Treatment Lucemyra (Lofexidine Hydrochloride) Approved for Opioid Withdrawal

Posted 17 May 2018 by Drugs.com

THURSDAY, May 17, 2018 – Lucemyra (lofexidine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat symptoms of opioid withdrawal. Withdrawal from an opioid painkiller can trigger symptoms including anxiety, agitation, sleep problems, muscle aches, sweating, nausea, diarrhea and drug craving. To prevent such symptoms, doctors typically recommend slow withdrawal from ...

FDA Approves Lucemyra (lofexidine hydrochloride) as the First Non-Opioid Treatment for Management of Opioid Withdrawal Symptoms

Posted 17 May 2018 by Drugs.com

May 16, 2018 – The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. While Lucemyra may lessen the severity of withdrawal symptoms, it may not completely prevent them and is only approved for treatment for up to 14 days. Lucemyra is not a treatment for opioid ...

Hit Hard by Opioid Crisis, Appalachian States Expand Clean-Needle Programs

Posted 11 May 2018 by Drugs.com

FRIDAY, May 11, 2018 – In 2013, there was just one clean-needle program in all of West Virginia, Kentucky and North Carolina, and the latter two states had laws banning such programs. Fast-forward four years: All of those laws have now been overturned and the number of "syringe services programs" available to help addicts has risen to over 50 across the three states, researchers report. ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Opiate Dependence

Related Drug Support Groups

methadone, clonidine, methocarbamol, Thorazine, chlordiazepoxide, Catapres, Methadose, chlorpromazine, Methadone Diskets, Dolophine, Lucemyra, lofexidine, Catapres-TTS-1, Ormazine